Total Payments
$22,727
2024 Payments
$235.55
Companies
30
Transactions
324
Medicare Patients
9,644
Medicare Billing
$1.4M
Payment Breakdown by Category
Gifts$13,931 (61.3%)
Food & Beverage$7,458 (32.8%)
Travel$884.68 (3.9%)
Other$383.32 (1.7%)
Education$70.16 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Gift | $13,931 | 1 | 61.3% |
| Food and Beverage | $7,458 | 303 | 32.8% |
| Travel and Lodging | $884.68 | 6 | 3.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $383.32 | 1 | 1.7% |
| Education | $70.16 | 13 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $13,931 | 1 | $0 (2019) |
| Abbott Laboratories | $5,240 | 93 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $701.08 | 50 | $0 (2023) |
| Medtronic, Inc. | $682.79 | 18 | $0 (2024) |
| Daiichi Sankyo Inc. | $520.77 | 36 | $0 (2019) |
| Purdue Pharma L.P. | $256.62 | 19 | $0 (2018) |
| PFIZER INC. | $198.96 | 22 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $133.43 | 9 | $0 (2021) |
| Avanir Pharmaceuticals, Inc. | $124.99 | 1 | $0 (2019) |
| GRT US Holding, Inc. | $109.95 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $235.55 | 11 | Medtronic, Inc. ($196.93) |
| 2023 | $634.03 | 13 | Medtronic, Inc. ($344.57) |
| 2022 | $861.88 | 21 | Abbott Laboratories ($473.85) |
| 2021 | $1,178 | 35 | Abbott Laboratories ($960.91) |
| 2020 | $723.52 | 28 | Abbott Laboratories ($558.83) |
| 2019 | $15,278 | 56 | Allergan Inc. ($13,931) |
| 2018 | $1,416 | 46 | Abbott Laboratories ($884.40) |
| 2017 | $2,400 | 114 | Abbott Laboratories ($1,367) |
All Payment Transactions
324 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Pain Management | ||||||
| 09/17/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $0.97 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/11/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $3.36 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/06/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $2.41 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/29/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/21/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $2.51 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/13/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/22/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $2.00 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 04/17/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $9.10 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 03/20/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Neuromodulation | ||||||
| 02/28/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $142.63 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/30/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $3.42 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/18/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.20 | General |
| Category: Opioid Analgesic | ||||||
| 10/13/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/12/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $159.22 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/30/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $123.14 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/19/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $5.75 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/07/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $89.43 | General |
| Category: Neuromodulation | ||||||
| 08/01/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $1.62 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 06/01/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 05/18/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $149.24 | General |
| Category: Neuromodulation | ||||||
| 04/22/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 04/17/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $15.20 | General |
| Category: Opioid Analgesic | ||||||
| 02/15/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/19/2022 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.81 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 2,587 | 5,497 | $1.7M | $324,568 |
| 2022 | 31 | 3,085 | 6,366 | $1.6M | $350,113 |
| 2021 | 34 | 2,073 | 3,829 | $1.6M | $404,110 |
| 2020 | 28 | 1,899 | 3,044 | $1.5M | $354,533 |
Total Patients
9,644
Total Services
18,736
Medicare Billing
$1.4M
Procedure Codes
135
All Medicare Procedures & Services
135 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 22514 | Treatment of broken lower spine bone with placement of stabilizing device | Office | 2023 | 14 | 17 | $204,000 | $66,629 | 32.7% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 225 | 249 | $105,875 | $59,309 | 56.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 263 | 395 | $65,520 | $31,898 | 48.7% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 280 | 497 | $124,250 | $30,163 | 24.3% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 132 | 154 | $38,500 | $16,820 | 43.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 213 | 283 | $36,920 | $16,672 | 45.2% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 94 | 124 | $100,000 | $12,195 | 12.2% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 53 | 57 | $108,500 | $11,733 | 10.8% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 75 | 99 | $76,835 | $9,529 | 12.4% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 58 | 77 | $18,275 | $5,962 | 32.6% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 62 | 75 | $121,300 | $5,595 | 4.6% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2023 | 33 | 49 | $40,930 | $5,588 | 13.7% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 74 | 97 | $36,925 | $5,358 | 14.5% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 21 | 24 | $36,000 | $4,887 | 13.6% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 234 | 507 | $32,550 | $4,534 | 13.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 55 | 72 | $29,900 | $3,642 | 12.2% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 36 | 47 | $47,000 | $3,608 | 7.7% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 53 | 57 | $28,500 | $3,585 | 12.6% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 74 | 99 | $5,800 | $3,365 | 58.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $7,920 | $3,359 | 42.4% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Facility | 2023 | 33 | 49 | $21,600 | $3,146 | 14.6% |
| 64625 | Destruction of nerves supplying joint between spine and pelvis using imaging guidance | Facility | 2023 | 14 | 15 | $36,000 | $3,127 | 8.7% |
| 64451 | Injection of anesthetic agent and/or steroid into spine and pelvis nerve using imaging guidance | Facility | 2023 | 24 | 35 | $12,215 | $2,891 | 23.7% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 46 | 62 | $24,800 | $2,352 | 9.5% |
| 0627T | Injection of cell or tissue-based material into spinal disc of lower back accessed through skin, first level | Facility | 2023 | 14 | 26 | $232,250 | $1,836 | 0.8% |
About Dr. Leonel Vance, MD
Dr. Leonel Vance, MD is a Interventional Pain Medicine healthcare provider based in Madison, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1669507943.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leonel Vance, MD has received a total of $22,727 in payments from pharmaceutical and medical device companies, with $235.55 received in 2024. These payments were reported across 324 transactions from 30 companies. The most common payment nature is "Gift" ($13,931).
As a Medicare-enrolled provider, Vance has provided services to 9,644 Medicare beneficiaries, totaling 18,736 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 135 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Pain Medicine
- Location Madison, MS
- Active Since 02/23/2007
- Last Updated 10/25/2021
- Taxonomy Code 208VP0014X
- Entity Type Individual
- NPI Number 1669507943
Products in Payments
- Proclaim Family of SCS IPGs (Device) $1,450
- DRG leads (Device) $998.24
- Proclaim IPG (Device) $946.06
- INTELLIS ADAPTIVESTIM (Device) $682.79
- PROCLAIM (Device) $672.42
- XTAMPZA (Drug) $350.17
- Movantik (Drug) $282.85
- SCS IPGs (Device) $265.58
- Xtampza ER (Drug) $256.79
- Morphabond ER (Drug) $237.92
- LYRICA (Drug) $156.33
- SYMPROIC (Drug) $142.99
- Octrode SCS Leads (Device) $134.43
- Amitiza (Drug) $131.28
- NUEDEXTA (Drug) $124.99
- Neuromodulation Dspsbls and Accs (Device) $122.82
- Qutenza (Drug) $109.95
- DRG IPGs (Device) $102.80
- Horizant (Drug) $99.66
- Axium INS DRG IPG (Device) $97.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.